Castelnau Le Lez, France Clinical Trials

A listing of Castelnau Le Lez, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 19 clinical trials
An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma

The overall aim of this project is to improve the outcome of patients diagnosed with ependymoma by improving and harmonising the staging and the standard of care of this patient population and to improve the investigators understanding of the underlying biology thereby informing future treatment. The program will evaluate new …

CHRU MONTPELLIER - H pital Arnaud de Villeneuve
 (1.9 away) Contact site
  • 25 views
  • 24 Jan, 2021
  • +61 other locations
Sodium Oxybate in Idiopathic Hypersomnia

this study evaluates of the efficacy of sodium oxybate on excessive daytime sleepiness using Epworth sleepiness scale over 8 weeks compared to placebo

sleepiness
sodium oxybate oral solution
xyrem
actigraphy
polysomnography
University Hospital of Montpellier
 (1.9 away) Contact site
  • 45 views
  • 19 Feb, 2021
  • 1 location
COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction

This study evaluates the benefit of colchicine on induced denervation after myocardial infarction. Patients who have suffered a documented De Novo myocardial infarction and completed a revascularization procedure will receive either colchicine on top of standard therapy, compared to standard therapy alone (1:1 allocation ratio). Colchicine 1mg (or 0.5mg) will …

UH Montpellier
 (1.9 away) Contact site
  • 0 views
  • 02 May, 2021
  • 1 location
Evaluation of a Marine OXYgen Carrier for Organ Preservation

Preventing ischemia/reperfusion injuries (IRIs) is a major issue in kidney transplantation, particularly for transplant recipients receiving a kidney from extended criteria donors (ECD). The main consequence of IRIs is delayed graft function (DGF). The medical device HEMO2life, an oxygen carrier developed by the Hemarina French Company, is a natural extracellular …

Montpellier
 (1.9 away) Contact site
  • 0 views
  • 24 Jan, 2021
  • +21 other locations
Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome

This protocol includes 2 independent studies. Both studies are multicenter studies, evaluating different therapeutic approaches in two different populations of patients: Study 1, a randomized phase-II study evaluating the efficacy of Intra-Arterial Chemotherapy (IAC) with melphalan and topotecan versus melphalan alone, both in association with ophthalmologic treatments. Study 2, a …

MONTPELLIER CHU Hopital Arnaud De Villeneuve
 (7.5 away) Contact site
  • 0 views
  • 13 Apr, 2021
  • +27 other locations
Efficacy & Safety of TD-1473 in Ulcerative Colitis

A Phase 2b/3 set of studies to evaluate the efficacy and safety of induction and maintenance therapy with TD-1473 in subjects with moderately-to-severely active ulcerative colitis with up to 60 weeks of treatment.

corticosteroids
immunomodulators
aminosalicylates
Theravance Biopharma Investigational Site
 (2.1 away) Contact site
  • 75 views
  • 28 Jan, 2021
  • +202 other locations
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

The ALL SCTped 2012 FORUM is a multinational, multi-centre, controlled, prospective phase III study for the therapy and therapy optimisation for children and adolescents with ALL in complete morphological remission (CR, less than 5% bone marrow blasts, no blasts in cerebrospinal fluid, no other extramedullary leukemia), who have an indication …

thiotepa
busulfan
thymoglobulin
remission
b-cell acute lymphoblastic leukemia
Hopital Arnaud de Villeneuve
 (7.5 away) Contact site
  • 389 views
  • 25 Jan, 2021
  • +157 other locations
Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma 5% DIF in Patients With Post-polio Syndrome

This is a multicenter, prospective, randomized, placebo-controlled, double-blind, parallel group clinical trial with adaptive dose selection in subjects with post polio syndrome (PPS). The main purpose of this study is to select a dose of Flebogamma 5% DIF and confirm the efficacy of the selected Flebogamma 5% DIF dose by …

CHU de Montpellier, H pital Lapeyronie
 (1.9 away) Contact site
  • 167 views
  • 29 Jan, 2021
  • +55 other locations
Nivolumab With Gemcitabine Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients

This study evaluates the addition of nivolumab to gemcitabine, oxaliplatin plus rituximab in case of B-cell lymphoma

nivolumab
rituximab
aggressive non-hodgkin's lymphoma
b-cell lymphoma
anthracyclines
CHU de Montpellier - H matologie Clinique
 (1.9 away) Contact site
  • 234 views
  • 02 Feb, 2021
  • +124 other locations
Study to Improve OS in 18 to 60 Year-old Patients Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

This open label, multicenter phase II/III study with multiple randomization phases at differents stages of AML treatment (induction, consolidation and HSCT where applicable) is designed to improve OS in younger (18 to 60 year-old) patients, with AML risk-adapted patient strategies. Within the intermediate risk AML group, optimal GvHD prophylaxis following …

cytarabine
idarubicin
induction chemotherapy
venetoclax
mycophenolate mofetil
Clinique du parc
 (1.0 away) Contact site
  • 42 views
  • 25 Jan, 2021
  • +56 other locations